DarioHealth (NASDAQ:DRIO) Stock Passes Below 200-Day Moving Average – What’s Next?

Shares of DarioHealth Corp. (NASDAQ:DRIO) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.81 and traded as low as $0.64. DarioHealth shares last traded at $0.68, with a volume of 100,221 shares.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. TD Cowen cut shares of DarioHealth from a “buy” rating to a “hold” rating and reduced their price target for the company from $2.00 to $1.00 in a report on Wednesday, January 29th. Stifel Nicolaus reduced their target price on shares of DarioHealth from $3.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, March 11th.

DarioHealth Stock Performance

The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.32 and a current ratio of 1.57. The firm has a market cap of $29.32 million, a price-to-earnings ratio of -0.75 and a beta of 1.42. The stock has a 50-day moving average of $0.69 and a 200-day moving average of $0.81.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. XTX Topco Ltd lifted its position in DarioHealth by 81.4% during the 3rd quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after buying an additional 13,219 shares in the last quarter. DLK Investment Management LLC increased its position in shares of DarioHealth by 40.9% in the fourth quarter. DLK Investment Management LLC now owns 141,657 shares of the company’s stock valued at $111,000 after acquiring an additional 41,107 shares during the last quarter. Finally, Appian Way Asset Management LP raised its holdings in DarioHealth by 2.5% during the third quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock worth $1,580,000 after acquiring an additional 34,990 shares in the last quarter. Institutional investors own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.